Review paper<br>Drug eluting stents in patients with type two diabetes

Łukasz Kuźma; Bożena Dobrzycka; Artur Dubicki; Sławomir Dobrzycki

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Contact Instructions for authors

2/2010
vol. 5

Send email

Copy url:

abstract:

Review paper
Drug eluting stents in patients with type two diabetes

Łukasz Kuźma

,

Bożena Dobrzycka

,

Artur Dubicki

,

Sławomir Dobrzycki

Przegląd Kardiodiabetologiczny 2010; 5 (2): 106–111

Online publish date: 2010/11/04

View full text Get citation

Diseases of the cardiovascular system are currently the main causes of death. Diabetics constitute a very important group of patients. The incidence of coronary heart disease in this group is five times higher than among non-diabetic patients. In the case of invasive treatment of coronary artery disease among patients with diabetes the factor that deteriorate prognosis is restenosis. Administration of antiproliferative drug-eluting stents, which inhibit formation of neointima and thus significantly reduce the incidence of restenosis, seems to be particulary benefitial for diabetics.

keywords:

Review paperDrug eluting stents in patients with type two diabetes

Łukasz Kuźma , Bożena Dobrzycka , Artur Dubicki , Sławomir Dobrzycki

drug eluting stents, ischaemic heart disease, diabetes mellitus

Review paper
Drug eluting stents in patients with type two diabetes

Łukasz Kuźma

,

Bożena Dobrzycka

,

Artur Dubicki

,

Sławomir Dobrzycki